Cancer remains one of the leading health challenges worldwide. With the advancement of precision medicine, Lenvatinib Capsules have emerged as a highly effective targeted therapy for several types of advanced cancers.
Cordium Pharmaceuticals Pvt Ltd is a trusted global pharmaceutical exporter dedicated to providing high-quality oncology medicines to healthcare providers, hospitals, distributors, and pharmacies across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What are Lenvatinib Capsules?
Lenvatinib is an oral targeted therapy used to treat various advanced cancers by inhibiting proteins that help cancer cells grow and spread.
Lenvatinib belongs to a class of medicines known as multikinase inhibitors (TKIs). It works by blocking tumor blood vessel formation (angiogenesis) and slowing cancer progression.
Medical Uses of Lenvatinib Capsules
Lenvatinib is prescribed for the treatment of:
1. Differentiated Thyroid Cancer (DTC)
Lenvatinib is used in patients with radioactive iodine-refractory differentiated thyroid cancer that has spread or progressed.
2. Hepatocellular Carcinoma (Liver Cancer)
Lenvatinib is recommended as a first-line treatment for unresectable liver cancer.
3. Advanced Renal Cell Carcinoma (Kidney Cancer)
Lenvatinib is used in combination with other therapies for advanced kidney cancer.
4. Advanced Endometrial Cancer
Lenvatinib, combined with Pembrolizumab, is used for advanced endometrial cancer.
How Does Lenvatinib Work?
Lenvatinib blocks several pathways involved in tumor growth, including:
VEGF receptors (VEGFR 1-3)
FGF receptors (FGFR 1-4)
PDGF receptors
RET receptors
KIT receptors
This mechanism helps:
✅ Reduce tumor blood supply
✅ Slow cancer cell multiplication
✅ Delay disease progression
✅ Improve progression-free survival
Benefits of Lenvatinib Capsules
Key Advantages:
Effective targeted cancer therapy
Oral capsule administration
Improved progression-free survival
Reduces tumor growth
Supports long-term cancer management
Internationally accepted oncology treatment option
Common Side Effects of Lenvatinib
Patients may experience:
High blood pressure
Fatigue
Diarrhea
Loss of appetite
Weight loss
Nausea
Protein in urine
Hand-foot syndrome
Mouth sores
Joint and muscle pain
Important: Lenvatinib should always be taken under oncologist supervision.
Recommended Monitoring During Treatment
Healthcare professionals may monitor:
Blood pressure
Liver function
Kidney function
Thyroid function
Urine protein levels
Electrolytes
Cardiac health
Regular monitoring improves treatment safety and effectiveness.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is committed to delivering high-quality oncology medicines worldwide.
Our strengths:
✔ Reliable global pharmaceutical exporter
✔ High-quality oncology products
✔ Competitive pricing
✔ Secure international logistics
✔ Regulatory compliance support
✔ Bulk supply for hospitals and distributors
✔ Professional export documentation
Countries We Serve
We supply Lenvatinib Capsules to:
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇵🇭 Philippines
🇻🇳 Vietnam
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
🇺🇸 USA
🇬🇧 UK
🇿🇦 South Africa
Our global network supports hospitals, oncology centers, government tenders, pharmacies, and pharmaceutical distributors.
